Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We measured 436 circulating proteins in serial blood samples from hospitalised and non-hospitalised ESKD patients with COVID-19 (n = 256 samples from 55 patients). Comparison to 51 non-infected patients revealed 221 differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Gisby, Jack, Clarke, Candice L, Medjeral-Thomas, Nicholas, Malik, Talat H, Papadaki, Artemis, Mortimer, Paige M, Buang, Norzawani B, Lewis, Shanice, Pereira, Marie, Toulza, Frederic, Fagnano, Ester, Mawhin, Marie-Anne, Dutton, Emma E, Tapeng, Lunnathaya, Richard, Arianne C, Kirk, Paul DW, Behmoaras, Jacques, Sandhu, Eleanor, McAdoo, Stephen P, Prendecki, Maria F, Pickering, Matthew C, Botto, Marina, Willicombe, Michelle, Thomas, David C, Peters, James E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Immunology and Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064756/
https://www.ncbi.nlm.nih.gov/pubmed/33704068
http://dx.doi.org/10.7554/eLife.64827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064756/
https://www.ncbi.nlm.nih.gov/pubmed/33704068
http://dx.doi.org/10.7554/eLife.64827

Ejemplares similares